CROSSJECT (EPA:ALCJ) | Finanzwire

Basculer en Français

8630	Companies
143980	Keywords
79657	Articles
76974	Press releases

Home
Companies
CROSSJECT

BRIEF

published on 03/27/2025 at 07:35, 30 days 19 hours ago

CROSSJECT Publishes 2024 Financial Results

Financial Results Cash Position Partnerships FDA Filing ZEPIZURE®
PRESS RELEASE

published on 03/27/2025 at 07:30, 30 days 19 hours ago

CROSSJECT reports financial results for 2024
CROSSJECT reports financial results for 2024 and progress in clinical and regulatory activities, recruitment of COO, and increased cash position. Key achievements and future plans outlined

Financial Results Cash Position Clinical Activities Crossject Regulatory Development
BRIEF

published on 03/25/2025 at 07:35, 1 month 1 day ago

Strategic partnership between CROSSJECT and ETON PHARMACEUTICALS

Eton Pharmaceuticals Crossject ZENEO® Hydrocortisone Adrenal Insufficiency
PRESS RELEASE

published on 03/25/2025 at 07:30, 1 month 1 day ago

CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program
CROSSJECT enhances collaboration with ETON PHARMACEUTICALS Inc. on ZENEO adrenal insufficiency program, introducing new hydrocortisone formulation for the hospital market

Eton Pharmaceuticals Crossject Hydrocortisone Adrenal Insufficiency ZENEO
BRIEF

published on 03/10/2025 at 14:22, 1 month 16 days ago

Crossject: Update on voting rights and shares as of January 31, 2025

Share Capital Voting Rights Actions Pharmaceutical Crossject
BRIEF

published on 02/12/2025 at 07:35, 2 months 14 days ago

Crossject Reappoints Key Members to Executive Board

Executive Board Crossject ZEPIZURE® Reappointment Needle-free Technology
PRESS RELEASE

published on 02/12/2025 at 07:30, 2 months 14 days ago

Crossject announces the reappointment of Patrick Alexandre and Isabelle Liebschutz as members of new, streamlined Executive Board
Crossject reappoints Patrick Alexandre and Isabelle Liebschutz to its Executive Board, focusing on final stages of ZEPIZURE registration with the FDA

Executive Board Crossject Patrick Alexandre Isabelle Liebschutz ZEPIZURE Registration
BRIEF

published on 02/06/2025 at 07:35, 2 months 20 days ago

Modification of Convertible Bonds by Crossject

Convertible Bonds Funding Crossject ZEPIZURE Heights Capital
PRESS RELEASE

published on 02/06/2025 at 07:30, 2 months 20 days ago

COMPLETION OF THE TRANSACTIONS ANNOUNCED IN DECEMBER 2024 RELATING TO THE AMENDMENT OF THE CONVERTIBLE BONDS SUBSCRIBED BY AN ENTITY AFFILIATED TO HEIGHTS CAPITAL MANAGEMENT, INC. (“HEIGHTS”) AND THE ISSUE OF A SECOND ASSIMILABLE TRANCHE
Crossject completes transactions announced in December 2024 related to amendment of convertible bonds subscribed by an entity affiliated to Heights Capital Management, Inc. Second assimilable tranche issued

Convertible Bonds Transaction Bond Issue Crossject Heights Capital Management
BRIEF

published on 01/20/2025 at 14:47, 3 months 6 days ago

Crossject: Update on voting rights and shares as of December 31, 2024

Share Capital Voting Rights Actions 2024 Crossject

1 2 ... 4

Accesswire

Published on 04/26/2025 at 02:00, 1 day 1 hour ago

Battery X Metals Announces Strategic Agreement to Advance Artificial Intelligence-Driven Exploration of Critical Battery Metals in Nevada, USA
Published on 04/25/2025 at 23:30, 1 day 3 hours ago

AIML Innovations Announces Departure of Tim Daniels from Board of Directors
Published on 04/25/2025 at 23:01, 1 day 4 hours ago

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2024
Published on 04/25/2025 at 23:00, 1 day 4 hours ago

AIML Optimizes Quantum Sciences Acquisition to Drive Growth & Strategic Focus
Published on 04/25/2025 at 22:15, 1 day 4 hours ago

Grande Portage Resources Announces Extension of Expiry Date for Warrants

View all ACCESSWIRE

EQS Group

Published on 04/25/2025 at 22:47, 1 day 4 hours ago

DEAG achieves new revenue level in “transformation year” 2024 – Strategic investments and strong start to the year create basis for future sustainable growth
Published on 04/25/2025 at 20:30, 1 day 6 hours ago

EQS-Adhoc: Nagarro SE: Confirms 2024 guidance and dividend, postpones publication for full-year results
Published on 04/25/2025 at 18:44, 1 day 8 hours ago

Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 04/25/2025 at 18:31, 1 day 8 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 04/25/2025 at 18:30, 1 day 8 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 04/25/2025 at 18:16, 1 day 8 hours ago

PR_Carrefour Brazil_25042025
Published on 04/25/2025 at 18:05, 1 day 9 hours ago

Louis Hachette Group - 2025 First-quarter revenue
Published on 04/25/2025 at 18:00, 1 day 9 hours ago

Availability of the 2024 universal registration document
Published on 04/25/2025 at 18:00, 1 day 9 hours ago

Postponement of the publication of the annual financial statements
Published on 04/25/2025 at 17:45, 1 day 9 hours ago

LANSON-BCC: GENERAL SHAREHOLDERS’ MEETING ON APRIL 25, 2025 - DIVIDEND: €0.90 PER SHARE

View all LES ECHOS COMFI WIRE